Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)

BIT:REC Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,758	10,347	10,042	7,959	11,657	9,330
Market Cap Growth	2.27%	3.04%	26.16%	-31.72%	24.95%	21.69%
Enterprise Value	12,790	11,683	11,569	9,335	12,386	10,196
Last Close Price	52.15	50.60	47.66	36.85	52.27	41.05
PE Ratio	26.09	24.84	25.80	25.48	30.20	26.28
Forward PE	20.73	20.92	22.69	20.55	28.63	24.43
PS Ratio	4.46	4.42	4.82	4.30	7.38	6.44
PB Ratio	5.44	5.51	5.96	5.15	8.44	7.31
P/FCF Ratio	19.71	19.40	22.04	18.18	24.81	24.40
P/OCF Ratio	18.43	18.16	20.69	17.24	23.71	23.12
PEG Ratio	1.91	1.94	2.42	1.58	7.31	7.31
EV/Sales Ratio	5.30	4.99	5.56	5.04	7.84	7.04
EV/EBITDA Ratio	14.32	13.71	15.28	14.16	20.92	18.24
EV/EBIT Ratio	17.88	16.73	18.46	17.15	24.55	21.44
EV/FCF Ratio	23.43	21.91	25.39	21.32	26.36	26.67
Debt / Equity Ratio	1.20	1.33	1.09	1.12	0.73	0.84
Debt / EBITDA Ratio	2.65	2.88	2.38	2.59	1.67	1.88
Debt / FCF Ratio	4.33	4.67	4.01	3.96	2.14	2.80
Asset Turnover	0.51	0.50	0.51	0.54	0.57	0.53
Inventory Turnover	1.64	1.55	1.45	1.58	1.78	1.70
Quick Ratio	1.05	1.02	0.76	0.77	0.95	0.87
Current Ratio	1.59	1.61	1.20	1.28	1.36	1.34
Return on Equity (ROE)	22.02%	23.38%	24.08%	21.34%	29.04%	28.69%
Return on Assets (ROA)	9.46%	9.34%	9.54%	9.99%	11.41%	10.77%
Return on Capital (ROIC)	11.31%	11.07%	11.53%	12.01%	13.32%	12.76%
Return on Capital Employed (ROCE)	17.10%	16.60%	19.50%	17.70%	23.00%	22.30%
Earnings Yield	3.88%	4.03%	3.88%	3.92%	3.31%	3.81%
FCF Yield	5.07%	5.15%	4.54%	5.50%	4.03%	4.10%
Dividend Yield	2.44%	2.51%	2.52%	3.12%	2.10%	2.56%
Payout Ratio	60.80%	60.92%	63.19%	73.83%	56.16%	59.92%
Buyback Yield / Dilution	0.04%	0.03%	-0.04%	0.01%	-0.01%	0.01%
Total Shareholder Return	2.48%	2.54%	2.48%	3.13%	2.09%	2.57%

Updated Jan 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.